Therapy Insight: Hepatopulmonary syndrome and orthotopic liver transplantation

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 11, 2007, Pages 614-621

  Pastor, Catherine M ^a   Schiffer, Eduardo ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN; PENTOXIFYLLINE;

BLOOD GAS ANALYSIS; BLOOD OXYGEN TENSION; CLINICAL TRIAL; COIL EMBOLIZATION; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; INTERMETHOD COMPARISON; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG DISEASE; MORBIDITY; MORTALITY; NONHUMAN; OXYGEN THERAPY; PATHOPHYSIOLOGY; PORTOSYSTEMIC ANASTOMOSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASODILATATION; WHOLE BODY SCINTISCANNING;

ALGORITHMS; ANIMALS; DIAGNOSIS, DIFFERENTIAL; EMBOLIZATION, THERAPEUTIC; HEPATOPULMONARY SYNDROME; HUMANS; LIVER TRANSPLANTATION; NITRIC OXIDE; OXYGEN INHALATION THERAPY; PENTOXIFYLLINE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PREVALENCE; RISK FACTORS; VASODILATOR AGENTS;

EID: 35848936037     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0965     Document Type: Review

References (38)

1. Rodriguez-Roisin R et al. (2005) Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol 42: 924-927
2. Palma DT and Fallon MB (2006) The hepatopulmonary syndrome. J Hepatol 45:617-625
3. Herve P et al. (2007) Pulmonary vascular abnormalities in cirrhosis. Best Pract Res Clin Gastroenterol 21: 141-159
4. Rodriguez-Roisin R et al. (2004) Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 24: 861-880
5. Swanson KL et al. (2005) Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology 41: 1122-1129
6. Gaines DI and Fallon MB (2004) Hepatopulmonary syndrome. Liver Int 24: 397-401
7. Gomez FP et al. (2004) Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology 40: 660-666
8. Abrams GA et al. (2002) Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl 8: 391-396
9. Schiffer E et al. (2006) Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: A prospective study in 90 patients. Am J Transpl 6: 1430-1437
10. Lima BL et al. (2004) Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 79: 42-48
11. Kim BJ et al. (2004) Characteristics and prevalence of intrapulmonary shunt detected by contrast echocardiography with harmonic imaging in liver transplant candidates. Am J Cardiol 94: 525-528
12. Abrams GA et al. (1998) Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: A new approach. Gastroenterology 114: 305-310
13. De BK et al. (2002) Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression. Gastroenterology 122: 897-903
14. Fuhrmann V et al. (2006) Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 131: 69-75
15. Arguedas MR and Fallon MB (2005) Hepatopulmonary syndrome. Clin Liver Dis 9: 733-746
16. Sammour RN et al. (2006) Pregnancy exacerbating hepatopulmonary syndrome. Obstet Gynecol 107: 455-457
17. Mandell MS (2006) The diagnosis and treatment of hepatopulmonary syndrome. Clin Liver Dis 10: 387-405.
18. Schenk P et al. (2002) Hepatopulmonary syndrome: Prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 51: 853-859
19. Mimidis KP et al. (1998) Prevalence of intrapulmonary vascular dilatations in normoxaemic patients with early liver cirrhosis. Scand J Gastroenterol 33: 988-992
20. Lange PA and Stoller JK (1995) The hepatopulmonary syndrome. Ann Intern Med 122: 521-529
21. Aller R et al. (1999) Diagnosis and grading of intrapulmonary vascular dilatation in cirrhotic patients with contrast transesophageal echocardiography. J Hepatol 31: 1044-1052
22. Fallon MB et al. (2006) Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl 12: S105-S107
23. Schenk P et al. (2003) Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125: 1042-1052
24. Mohamed R et al. (2002) Pulmonary gas exchange abnormalities in liver transplant candidates. Liver Transpl 8: 802-808
25. Swanson KL (2007) Should we screen for hepatopulmonary syndrome in liver transplant candidates? Liver Transpl 13: 183-184
26. United Network for Organ Sharing. Organ distribution: Allocation of livers [http://www.unos.org/policiesandbylawstpolicies.asp?ressources= true] (accessed 5 September 2007)
27. Tailld C et al. (2003) Liver transplantation for hepatopulmonary syndrome: A ten-year experience in Paris, France. Transplantation 75: 1482-1489
28. Krowka MJ et al. (2004) Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database. Liver Transpl 10: 174-182
29. Arguedas MR et al. (2003) Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37: 192-197.
30. Collisson EA et al. (2002) Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl 8: 925-931
31. Fukushima KY et al. (2007) Two cases of hepatopulmonary syndrome with improved liver function following long-term oxygen therapy. J Gastroenterol 42: 176-180
32. Martínez-Palli G et al. (2005) Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. Worfd J Gastroenterol 11: 6858-6862
33. Lasch HM et al. (2001) Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl 7: 147-149
34. Rolla G et al. (1994) Methylene blue in the hepatopulmonary syndrome. N Engl J Med 331: 1098
35. Schenk P et al. (2000) Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 133: 701-706
36. G-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 362: 43-44
37. Gomez FP et al. (2006) Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 43:1084-1091
38. Almeida JA et al. (2007) Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome. Eur J Gastroenterol Hepatol 19: 341-346